Read More
EUR 75 Million Deal: This Low PE, High ROCE Pharma Company Enters Exclusive...
Lupin's wholly owned subsidiary VISUfarma will receive exclusive rights for regulatory activities, m...
Articles tagged with "Lupin Ltd"
Read More
Lupin Secures USFDA Nod for Diazepam Injection, Targets USD 77.9 Million Ma...
Lupin has strengthened its US generics business after securing USFDA approval for Diazepam Injection...
Read More
Stocks to Watch Tomorrow...
Fresh order wins, strategic partnerships and a key European regulatory approval could keep Coal Indi...
Read More
Lupin Extends Timeline For Philippines Subsidiary Acquisition; Completion E...
Lupin said completion of its proposed acquisition of minority shareholding in Multicare Pharmaceutic...
Read More
Indian Pharma Major Receives China Approval; Marks Entry Into Chinese Marke...
Lupin received approval from China’s National Medical Products Administration for Oseltamivir Phosph...
Read More
Lupin Reports 88% Jump in Q4FY26 Profit; Announces Rs 18 Dividend Amid Stro...
Lupin reported Q4FY26 consolidated profit after tax of Rs 1,413.07 crore on revenue from operations ...
Read More
Overnight Digest: Stocks to Watch on Monday – April 06, 2026...
Stocks to watch on Monday, April 6, 2026: Lupin, Tata Motors, Maruti Suzuki, and Astra Microwave Pro...
Read More
Lupin Shares Recover Following VISUfarma Acquisition, Up ~250% Over 3 Years...
Lupin Ltd completes VISUfarma acquisition, expands its ophthalmology portfolio in Europe, and shows ...
Read More
Lupin Signs License and Supply Agreement with Spektus to Commercialise Nove...
This collaboration significantly strengthens Lupin’s Central Nervous System (CNS) portfolio, providi...
Read More
Lupin Launches Dasatinib Tablets in the United States...
Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics...